Stefano Bartesaghi, Kristina Wallenius, Daniel Hovdal, Mathias Liljeblad, Simonetta Wallin, Niek Dekker, . . . Xiao-Rong Peng. (2022). Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice. Elsevier.
Chicago Style (17th ed.) CitationStefano Bartesaghi, et al. Subcutaneous Delivery of FGF21 MRNA Therapy Reverses Obesity, Insulin Resistance, and Hepatic Steatosis in Diet-induced Obese Mice. Elsevier, 2022.
MLA (9th ed.) CitationStefano Bartesaghi, et al. Subcutaneous Delivery of FGF21 MRNA Therapy Reverses Obesity, Insulin Resistance, and Hepatic Steatosis in Diet-induced Obese Mice. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.